USPTO serial 98493564
ACCESS HUB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 10, 2026
- Examiner
- HAN, JOANNA Y
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ACCESS HUB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Aventura, FL, US
Aventura, FL, US
Aventura, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie A. Greenberg
Julie A. Greenberg Reising Ethington P.C.755 W Big Beaver Rd, Suite 1850Troy, MI 48084United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the field of medicine, therapeutics, pharmacology, pharmaceuticals, medical market access, and medical and pharmaceutical economics; Downloadable data sets, reports, and electronic publications in the nature of periodic reports, newsletters, and periodic industry guidelines in the fields of medical and pharmaceutical businesses, medical and pharmaceutical commerce, medical and pharmaceutical pricing, medical market access, pharmaceutical distribution, scientific research, medicine, pharmacology, medical diagnostics, and drugs | ACTIVE | Feb 24, 2021 |
| 035 | Business and commercial pharmaceutical market analysis and information services; Gathering, monitoring, compiling, analyzing, and providing business and commercial information, news, and insights in the nature of providing business and commercial information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing business information, data, and analytics in the field of pharmaceutical markets in the nature of providing business and commercial information providing business information and market analysis services in the field of pharmaceuticals | ACTIVE | Feb 24, 2021 |
| 036 | Gathering, monitoring, compiling, analyzing, and providing financial and insurance information, news, and insights in the nature of financial and insurance information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; providing financial and insurance information, data, and analytics in the nature of financial and insurance information in the field of pharmaceuticals and pharmaceutical markets; Financial analysis and insurance information services in the field of pharmaceutical markets | ACTIVE | Feb 24, 2021 |
| 042 | Gathering, monitoring, compiling, analyzing, and providing scientific and scientific research information, news, and insights in the nature of providing scientific information and scientific research information in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Software as a service (SAAS) featuring software for providing monitoring, analytics, modeling, information, data, news, and insights in the fields of medicine, therapeutics, pharmacology, pharmaceuticals, medical diagnostics, pharmaceutical distribution, medical market access, and medical and pharmaceutical markets, and regarding business, commerce, finance, scientific research, and medical and pharmaceutical economics; Providing scientific and scientific research information, data, and analytics in the nature of providing scientific information and scientific research information regarding pharmaceuticals; Scientific and scientific research information analysis services in the nature of providing scientific information, scientific research information and scientific analysis in the field of pharmaceuticals; Software as a service (SAAS) featuring software for providing information, data, and analytics regarding pharmaceuticals and market, distribution, pricing, market access, and economic information related to pharmaceuticals | ACTIVE | Feb 24, 2021 |
| 044 | Medical information relating to medical, therapeutic, pharmacological, and pharmaceutical fields; Medical information and medical analysis relating to medical, therapeutic, pharmacological, and pharmaceutical fields for diagnostic and treatment purposes provided by medical laboratories; Gathering, monitoring, compiling, analyzing, and providing medical, therapeutic, pharmacological, pharmaceutical, and medical diagnostic information, news, and insights in the nature of medical information in the fields of pharmaceutical distribution, medical market access, medical and pharmaceutical markets, and medical and pharmaceutical economics; Providing medical research information in the field of pharmaceuticals | ACTIVE | Feb 24, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IPD Analytics, LLC
- Other trademarks owned by IPD Analytics, LLC
- Other trademarks owned by IPD Analytics, LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACCESS HUB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 20, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 20, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2026 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 14, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 14, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 5, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 22, 2025 | IUAF | USE AMENDMENT FILED | — |
| Jul 22, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 6, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 19, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 19, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 19, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 10, 2024 | NWAP | NEW APPLICATION ENTERED | — |